Haverkamp W - Search Results

1

Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.

Madeja M, Leicher T, Friederich P, Punke MA, Haverkamp W, Musshoff U, Breithardt G, Speckmann EJ. Madeja M, et al. Among authors: haverkamp w. Mol Pharmacol. 2003 Mar;63(3):547-56. doi: 10.1124/mol.63.3.547. Mol Pharmacol. 2003. PMID: 12606761

2

Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.

Rolf S, Haverkamp W, Borggrefe M, Musshoff U, Eckardt L, Mergenthaler J, Snyders DJ, Pongs O, Speckmann EJ, Breithardt G, Madeja M. Rolf S, et al. Among authors: haverkamp w. Naunyn Schmiedebergs Arch Pharmacol. 2000 Jul;362(1):22-31. doi: 10.1007/s002100000257. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10935529

3

Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.

Mergenthaler J, Haverkamp W, Hüttenhofer A, Skryabin BV, Musshoff U, Borggrefe M, Speckmann EJ, Breithardt G, Madeja M. Mergenthaler J, et al. Among authors: haverkamp w. Naunyn Schmiedebergs Arch Pharmacol. 2001 Apr;363(4):472-80. doi: 10.1007/s002100000392. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11330342

4

Electrophysiologic effects of potassium channel openers.

Haverkamp W, Borggrefe M, Breithardt G. Haverkamp W, et al. Cardiovasc Drugs Ther. 1995 Mar;9 Suppl 2:195-202. doi: 10.1007/BF00878466. Cardiovasc Drugs Ther. 1995. PMID: 7647023 Review.

5

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.

Eckardt L, Breithardt G, Haverkamp W. Eckardt L, et al. Among authors: haverkamp w. J Pharmacol Exp Ther. 2002 Jan;300(1):64-71. doi: 10.1124/jpet.300.1.64. J Pharmacol Exp Ther. 2002. PMID: 11752098

6

Antiarrhythmic therapy in heart failure.

Eckardt L, Haverkamp W, Breithardt G. Eckardt L, et al. Among authors: haverkamp w. Heart Fail Monit. 2002;2(4):110-9. Heart Fail Monit. 2002. PMID: 12634885 Review.

7

Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.

Kirchhof P, Milberg P, Eckardt L, Breithardt G, Haverkamp W. Kirchhof P, et al. Among authors: haverkamp w. J Cardiovasc Pharmacol. 2003 Apr;41(4):640-8. doi: 10.1097/00005344-200304000-00018. J Cardiovasc Pharmacol. 2003. PMID: 12658067

8

How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.

Borggrefe M, Haverkamp W, Shenasa M, Hindricks G, Breithardt G. Borggrefe M, et al. Among authors: haverkamp w. J Cardiovasc Pharmacol. 1992;20 Suppl 2:S32-40. J Cardiovasc Pharmacol. 1992. PMID: 1279307 Review.

9

Sodium channel blockers in the treatment of ventricular arrhythmias: different effects in the normal, ischaemic or failing heart?

Haverkamp W, Hindricks G, Fechtrup C, Borggrefe M, Breithardt G. Haverkamp W, et al. Eur Heart J. 1991 Dec;12 Suppl F:10-7. doi: 10.1093/eurheartj/12.suppl_f.10. Eur Heart J. 1991. PMID: 1666550 Review.

10

Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.

Chen X, Borggrefe M, Martinez-Rubio A, Hief C, Haverkamp W, Hindricks G, Breithardt G. Chen X, et al. Among authors: haverkamp w. J Cardiovasc Pharmacol. 1994 Oct;24(4):664-9. doi: 10.1097/00005344-199410000-00018. J Cardiovasc Pharmacol. 1994. PMID: 7528850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters